Sign In
Buy CRSP
$46.99
-0.790 (-1.65%)
At Close: Jul 20, 2026
CRISPR Therapeutics AG (CRSP) Reports Q2 Loss, Lags Revenue Estimates
06:56pm, Monday, 04'th Aug 2025
CRISPR Therapeutics AG (CRSP) came out with a quarterly loss of $1.29 per share versus the Zacks Consensus Estimate of a loss of $1.47. This compares to a loss of $1.49 per share a year ago.
CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results
04:15pm, Monday, 04'th Aug 2025
-CASGEVY ® momentum building; >75 authorized treatment centers (ATCs) activated globally, achieving the target goal and ~115 patients have had cells collected across all regions; positioning the pro
New Strong Sell Stocks for August 1st
06:16am, Friday, 01'st Aug 2025
CRSP, CSTL and SIGI have been added to the Zacks Rank #5 (Strong Sell) List on August 1, 2025.
CRISPR Therapeutics AG (CRSP) Sees a More Significant Dip Than Broader Market: Some Facts to Know
06:50pm, Thursday, 31'st Jul 2025
In the most recent trading session, CRISPR Therapeutics AG (CRSP) closed at $56.26, indicating a -2.46% shift from the previous trading day.
Should You Invest in CRISPR Therapeutics (CRSP) Based on Bullish Wall Street Views?
10:31am, Wednesday, 30'th Jul 2025
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employe
New Strong Sell Stocks for July 29th
07:46am, Tuesday, 29'th Jul 2025
BUR, CRSP and CNL have been added to the Zacks Rank #5 (Strong Sell) List on July 29, 2025.
The 3 Things That Matter for CRISPR Therapeutics Now
06:00am, Tuesday, 29'th Jul 2025
Biotechnology outfit CRISPR Therapeutics (CRSP -1.37%) isn't a name on many investors' radar -- and understandably so. Its market capitalization is a mere $6 billion.
CRISPR Therapeutics AG (CRSP) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
11:06am, Monday, 28'th Jul 2025
CRISPR Therapeutics (CRSP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CRISPR Therapeutics AG (CRSP) Stock Falls Amid Market Uptick: What Investors Need to Know
06:51pm, Friday, 25'th Jul 2025
CRISPR Therapeutics AG (CRSP) concluded the recent trading session at $64.76, signifying a -1.97% move from its prior day's close.
CRISPR Therapeutics AG (CRSP) Stock Slides as Market Rises: Facts to Know Before You Trade
07:01pm, Thursday, 24'th Jul 2025
CRISPR Therapeutics AG (CRSP) closed the most recent trading day at $66.06, moving 3.05% from the previous trading session.
Crispr Therapeutics: Shares Are Soaring - This Could Be The Start Of Something Big
11:03am, Wednesday, 23'rd Jul 2025
Crispr Therapeutics AG stock has surged nearly 90% since my Buy call in early May, reaching its highest value since February 2024. The rally builds on the historic approval of Casgevy, a gene editing
2 Biotech and 2 Tech Stocks Insiders Are Scooping Up Now
08:45am, Wednesday, 23'rd Jul 2025
Insider buying has been slow this month, as buy windows close ahead of the new earnings-reporting season.
CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know
10:01am, Tuesday, 22'nd Jul 2025
Zacks.com users have recently been watching CRISPR Therapeutics (CRSP) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Nearly 89% of Companies are Seeing Insider Selling, But these 3 are Seeing Substantial Buying
09:25am, Tuesday, 22'nd Jul 2025
Corporate insiders have taken a sharply pessimistic turn – selling their companies' shares at the fastest rate in at least a decade.
3 Monster Stocks in the Making to Buy Right Now
12:07am, Monday, 21'st Jul 2025
Where can you find the next monster stocks? Check out the biotech space.
